Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

In Cancer, an Embryonic Mechanism Gone Awry

Published: Monday, October 08, 2012
Last Updated: Monday, October 08, 2012
Bookmark and Share
Many types of cancer could originate from a mechanism that cells use to silence genes.

This process, which is essential in embryonic development, might be accidentally reactivated in tumor cells, according to EPFL scientists.

There are some genes that are only activated in the very first days of an embryo’s existence. Once they have accomplished their task, they are shut down forever, unlike most of our genes, which remain active throughout our lives. EPFL scientists have unveiled part of this strange mechanism. The same process, accidentally initiated later in life, could be responsible for many kinds of cancer. The discovery is described in a recent article in the journal Cell Reports.

The researchers identified a group of proteins that play a key role in this phenomenon. They bind to a DNA sequence near the gene, and substitute one DNA element for another, essentially “marking” the sequence. This phenomenon is known as “methylation.” Once the marker is in place, the cellular machinery recognizes the sign and maintains the gene in a dormant state.

“It’s an extremely elegant mechanism. The genes are needed right at the beginning of embryonic development, but rather than deactivate them every time a cell divides, the job is done in one fell swoop, once the genes are no longer required,” explains EPFL professor Didier Trono, who co-authored the article. “This process is also involved in the control of viral sequences, which make up almost half of our genome, and must be inactivated very early in development.”

This gene-silencing mechanism, which normally takes place in a several-day-old embryo, can also occur accidentally later in life. In many cancer cells, certain genes have been marked by methylation; they have been silenced. If, for example, the gene responsible for controlling cell division has been methylated, the consequences are all too easy to imagine. “The embryonic process, which is designed to silence certain genes, can be fortuitously reactivated, leading to the formation of tumor cells.”

It is still not understood why the process stops after the first days of embryogenesis, even though many of the active proteins continue to be expressed in the cell, says Trono. “If we can figure out how this cellular clock works, then we would perhaps be able to understand how the mechanism is reactivated later, leading to the development of cancer.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

A “Micro Winery” That Makes Wine Continuously
An American professor, working in collaboration with EPFL, is developing a miniature device for producing wine non-stop and testing different fermentation processes.
Wednesday, July 06, 2016
Reclaiming The Immune System's Assault On Tumors
EPFL study shows a way to reclaim corrupted immune cells.
Wednesday, June 15, 2016
Intestinal Worms Boost Immune System In A Surprising Way
EPFL researchers find that intestinal worm infections cause lymph nodes to produce more immune cells as well as grow in size.
Friday, May 06, 2016
Improved Animal Model for Breast Cancer
EPFL scientists have developed an animal model for breast cancer that faithfully captures the disease. Tested on human breast tissue, this the most clinically realistic model for breast cancer to date.
Friday, March 04, 2016
Rapid, Highly Sensitive Diagnostics
A portable and low-cost diagnostic device has been developed at EPFL. This microfluidic tool, which has been tested with Ebola, requires no bulky equipment. It is thus ideally suited for use in remote regions.
Tuesday, February 23, 2016
Observing Brain Diseases in Real Time
An innovative tool allows researchers to observe protein aggregation throughout the life of a worm.
Monday, February 15, 2016
What do Banana Peels and Human Skin Have in Common?
Human skin and banana peels have something in common: they produce the same enzyme when attacked. By studying fruit, researchers have come up with an accurate method for diagnosing the stages of this form of skin cancer.
Tuesday, February 09, 2016
A Better Model for Parkinson's
Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development.
Wednesday, February 03, 2016
Squeezing Cells into Stem Cells
EPFL scientists have developed a new method that helps cells turn in usable stem cells. The new approach involves “squeezing” cells with a gel, and paves the way for large-scale production of stem cells for medical purposes.
Tuesday, January 12, 2016
Super-Fine Solution to Sponge Up Micropollutants
A super-fine form of powdered activated carbon captures micropollutants more rapidly than the conventional kind and could by used in Swiss wastewater treatment plants, say EPFL researchers in a new study.
Friday, January 08, 2016
Treating Colon Cancer with Vitamin A
Scientists at EPFL identify the biological pathway behind the growth of colon cancer, and block it with vitamin A.
Wednesday, December 16, 2015
Out Now: A Microscope that Sees Live Cells in 3D
EPFL spin-off Nanolive has launched the 3D Cell Explorer, a microscope for observing living cells in 3D. This new tool could be a real boon for researchers in such areas as infertility.
Thursday, December 10, 2015
Antidepressants Plus Blood-Thinners Slow Down Brain Cancer
EPFL scientists have found that combining antidepressants with anticoagulants slows down brain tumors (gliomas) in mice.
Monday, September 28, 2015
DNA Sequencing Improved by Slowing Down
EPFL scientists have developed a method that improves the accuracy of DNA sequencing up to a thousand times.
Thursday, September 24, 2015
Preventing Crystallization to Improve Drug Efficiency
Esther Amstad and an international team of researchers have developed a method to increase the solubility of poorly soluble substances, such as many of the newly developed drugs.
Thursday, September 17, 2015
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos